ArticleClinical transplantation2022

Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.

Meghan Pearl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.